Kalambokis Georgios, Christou Leonidas, Stefanou Dimitrios, Arkoumani Evdokia, Tsianos Epameinondas V
Medical School of Ioannina, 45110 Ioannina, Greece.
World J Gastroenterol. 2007 Nov 21;13(43):5783-6. doi: 10.3748/wjg.v13.i43.5783.
A high incidence of IgA nephropathy has been reported in patients with liver cirrhosis, though, clinically evident nephrotic syndrome is very uncommon. Impaired hepatic clearance of circulating IgA immune complexes and subsequent deposition in renal glomeruli has been considered principally in the pathogenesis of liver cirrhosis associated IgA nephropathy. Here we report on a patient with cryptogenic liver cirrhosis and splenic vein thrombosis, who presented with nephrotic syndrome. Renal biopsy showed findings consistent with IgA nephropathy. Lower endoscopy showed features of portal hypertensive colopathy. Following initiation of propranolol and anticoagulant treatment to reduce portal pressure, a gradual decrease of proteinuria and hematuria to normal range was noted. The potential pathogenetic role of portal hypertension in the development of IgA nephropathy in cirrhotic patients is discussed.
已有报道称肝硬化患者中IgA肾病的发病率较高,不过临床上明显的肾病综合征非常少见。循环IgA免疫复合物的肝脏清除受损以及随后在肾小球中的沉积,主要被认为与肝硬化相关IgA肾病的发病机制有关。在此,我们报告一名患有隐源性肝硬化和脾静脉血栓形成的患者,该患者表现为肾病综合征。肾活检显示的结果与IgA肾病一致。低位内镜检查显示有门静脉高压性结肠病的特征。在开始使用普萘洛尔和抗凝治疗以降低门静脉压力后,发现蛋白尿和血尿逐渐降至正常范围。本文讨论了门静脉高压在肝硬化患者IgA肾病发生中的潜在致病作用。